Skip to main content
. 2019 May 3;10(6):934–945. doi: 10.1039/c9md00088g

Table 1. Minimum pharmacophore determination. Compounds were tested for activity against M. tuberculosis (MBC4.5) and HepG2 cells (IC50). MBC4.5 are reported as the median. HepG2 IC50 are reported as the mean ± standard deviation. The number of replicates is in parentheses.

Inline graphic
Cpd ID R1 R2 MBC4.5 (μM) HepG2 IC50 (μM)
1 IDR-0019306 2,4-Cl–Ph–NH- 4-Br–Ph–SO2- 6.3 (5) 6.2 ± 1.1 (3)
3 IDR-0597329 4-Cl–Ph–NH- 4-Br–Ph–SO2- 50 (2) 11 ± 4.7 (2)
4 IDR-0484542 PhNH- 4-Br–Ph–SO2- 100 (2) 30 ± 3.5 (2)
5 IDR-0597554 EtNH- 4-Br–Ph–SO2- >200 (3) >100 (3)
6 IDR-0597555 H2N- 4-Br–Ph–SO2- >200 (3) >100 (3)
7 IDR-0596462 2,4-Cl–Ph–NH- Ph–SO2- >200 (4) 19 ± 9.2 (2)
8 IDR-0596461 2,4-Cl–Ph–NH- Me–SO2- 75 (2) 78 ± 29 (2)
9 IDR-0597928 2,4-Cl–Ph–NH- H- 200 (4) 40 ± 2.3 (3)